Moloxin (Moxifloxacin)

Moxifloxacin, the active ingredient in Moloxin, is a fluoroquinolone antibiotic presented as an injection solution for intravenous use. It treats a range of serious bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, complicated skin and soft‑tissue infections, complicated intra‑abdominal infections, and acute exacerbations of chronic bronchitis in adult patients.

GNH USA supplies Moloxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is indicated for several bacterial infections affecting the respiratory, sinus, skin, and intra‑abdominal systems.

Community‑acquired bacterial pneumonia: achieves clinical cure and bacterial eradication in adult patients. Acute bacterial sinusitis: resolves infection and alleviates sinus inflammation. Complicated skin and soft‑tissue infections: clears pathogenic bacteria and promotes tissue healing. Complicated intra‑abdominal infections: provides broad‑spectrum coverage for mixed aerobic and anaerobic organisms. Acute exacerbations of chronic bronchitis: reduces bacterial load and improves respiratory function.

Moxifloxacin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial pain.

Serious or Rare Side Effects: - Tendon rupture: risk of sudden tendon failure, especially in the Achilles. - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe allergic reaction: includes anaphylaxis, angioedema, and skin rash.

When using Moloxin, clinicians should observe several precautionary measures to minimize risk.

Renal function: adjust dosing in patients with severe renal impairment. QT interval: monitor ECG in individuals with known QT prolongation or electrolyte disturbances. Concurrent fluoroquinolone use: avoid combination to reduce resistance development. Allergy: discontinue immediately if hypersensitivity reactions occur. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moxifloxacin can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin. - Warfarin: may increase anticoagulant effect and risk of bleeding. - Theophylline: increased risk of theophylline toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Cyclosporine: may elevate serum cyclosporine concentrations. - Diabetes medications: potential alteration of glucose control.